Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088

NCT04802057 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Haemolytic Anaemia

Interventions

DRUG: SAR445088

Sponsor

Bioverativ, a Sanofi company